Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1 hedge funds and large institutions have $0 invested in Allergan plc in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $2.75M → $0 (-$2.75M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ABC
Associated Banc-Corp
Green Bay,
Wisconsin
|
-$2.75M |
AGN Hedge Fund Activity: Q2 2021 in Review
1 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2021, worth a combined $0 — down 100% from $2.75M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AGN and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Associated Banc-Corp, exiting entirely with an estimated $2.75M sold.
- 1 institutional investor held Allergan plc (AGN) as of Q2 2021, down from 2 in Q1 2021.
- Funds reported $0 of Allergan plc stock for Q2 2021, down 100% quarter-over-quarter.
- 0 funds opened new Allergan plc positions in Q2 2021 and 1 closed out, a net change of -1 holder.
- The largest Allergan plc seller in Q2 2021 was Associated Banc-Corp, an estimated $2.75M sold.
Based on aggregated 13F filings for Q2 2021.